07:52 AM EST, 12/03/2024 (MT Newswires) -- Keros Therapeutics ( KROS ) said Tuesday it has agreed to provide Takeda Pharmaceutical ( TAK ) with a global commercial license for elritercept, as well as to collaborate on the drug candidate's development. Keros said it expects to receive an upfront payment of $200 million, with milestone payments that could reach up...

07:47 AM EST, 12/03/2024 (MT Newswires) -- Coherus BioSciences ( CHRS ) said Tuesday that it has agreed to divest its biosimilar drug Udenyca, which is based on Amgen's ( AMGN ) Neulasta, to Intas Pharmaceuticals for up to $558.4 million. The company said the transaction includes an upfront payment of $483.4 million, as well as $75 million in potential...

07:49 AM EST, 12/03/2024 (MT Newswires) -- Dynamite Blockchain (BLOX.CN) on Tuesday entered into a binding arm's length securities exchange agreement as it moved to buy all outstanding shares of Kaspa Mining Limited for a total consideration of about C$4.8 million. The total consideration for the acquisition will be 30 million common shares of the company, at a deemed issue...

07:49 AM EST, 12/03/2024 (MT Newswires) -- Despite the positivity brought on by upward revisions to Canada's real gross domestic product, one sore spot remains: growth lags the still-strong population surge, noted Bank of Montreal (BMO). In fact, real GDP per capita has been declining for six straight quarters to Q3, which ties the early 1980s for the longest such...